Page 112 - 《中国药房》2023年9期
P. 112

·药师与药学服务·


          贵州省老年结核病患者多重用药负担及影响因素分析
                                                                                             Δ

                 1*
                           2
                                   1
          胡元霞 ,王 芸 ,方世林 ,禄晓龙 (1.贵州医科大学医药卫生管理学院,贵阳 550025;2.贵州医科大学环境
                                           1 #
          污染与疾病监控教育部重点实验室/公共卫生与健康学院,贵阳 550025)
          中图分类号  R52;R95      文献标志码  A      文章编号  1001-0408(2023)09-1126-05
          DOI  10.6039/j.issn.1001-0408.2023.09.19

          摘   要  目的  了解贵州省老年结核病患者多重用药负担及其影响因素,为减轻患者用药负担提供参考依据。方法  2022年4-7
          月,采用便利抽样法在贵州省贵阳市、毕节市、黔东南苗族侗族自治州三地的3所结核病定点医院抽取405例老年结核病门诊患者
          作为调查对象,采用一般情况调查表、用药生活问卷(LMQ)进行面对面调查。运用描述性分析、单因素方差分析、多元线性回归
          分析了解老年结核病患者的多重用药负担得分情况并探讨影响老年结核病患者多重用药负担的因素。结果  405例老年结核病
          患者的多重用药负担总得分为(112.65±14.59)分,高于 LMQ 高负担标准的阈值(110 分)。多元线性回归分析结果显示,年龄
          80~92岁、自费+医保、复治、耐药、有药物不良反应是老年结核病患者多重用药负担的危险因素(P<0.05);居住地为城镇和服药
          管理方式为家庭成员管理、志愿者管理、智能工具辅助管理是其保护因素(P<0.05)。结论  贵州省老年结核病患者的多重用药负
          担较重,且受患者年龄、居住地、药费支付方式、治疗分类、是否耐药、药物不良反应、服药管理方式的影响。医护人员应根据多重
          用药负担的影响因素为重点人群提供用药指导和帮助,以减轻其多重用药负担。
          关键词  结核病;多重用药负担;老年人;影响因素


          Analysis  of  the  burden  of  polypharmacy  and  its  influencing  factors  among  elderly  tuberculosis  patients  in
          Guizhou province
                                                1
                                                              1
                                  2
                     1
          HU Yuanxia ,WANG Yun ,FANG Shilin ,LU Xiaolong (1.  School  of  Medicine  and  Health  Management,
          Guizhou Medical University, Guiyang 550025, China;2. Key Laboratory of Environmental Pollution Monitoring
          and  Disease  Control,  Ministry  of  Education/School  of  Public  Health,  Guizhou  Medical  University,  Guiyang
          550025, China)
          ABSTRACT    OBJECTIVE  To  understand  the  polypharmacy  burden  and  influencing  factors  of  elderly  tuberculosis (TB)  in
          Guizhou  province,  and  to  provide  reference  for  reducing  the  polypharmacy  burden  of  patients.  METHODS  From  April  to  July
          2022, 405 elderly TB outpatients were selected from three designated TB hospitals in Guiyang City, Bijie City, and Qiandongnan
          Miao and Dong Autonomous Prefecture of Guizhou Province by convenience sampling method as investigation objects. The general
          situation questionnaire and the Living with Medicines Questionnaire (LMQ) were used for face-to-face survey. Descriptive analysis,
          one-way ANOVA  and  multivariate  linear  regression  analysis  were  used  to  understand  the  score  of  polypharmacy  burden  of  elderly
          TB patients and explore the factors effecting polypharmacy burden in TB patients. RESULTS The total polypharmacy burden score
          of 405 elderly TB patients was (112.65±14.59) points, which was higher than the threshold (110 points) for high burden standard
          in  LMQ.  Multivariate  linear  regression  analysis  showed  that  aged  80  to  92  years,  self-financed+medical  insurance,  retreatment,
          drug resistance, and adverse drug reactions were the risk factors for polypharmacy burden in elderly TB patients (P<0.05); living
          in  the  city,  family  member  management,  volunteer  management  and  intelligent  tool-assisted  management  were  the  protective
          factors (P<0.05).  CONCLUSIONS  The  burden  of  polypharmacy  in  elderly TB  patients  from  Guizhou  province  is  heavy,  and  is
          influenced  by  patient’s  age,  residence,  payment  method,  treatment  classification,  drug  resistance,  adverse  drug  reactions,  and
          medication  management.  It  is  recommended  that  medical  staff  should  provide  key  populations  with  medication  guidance  based  on
          influential factor for polypharmacy burden so as to reduce their polypharmacy burden.
                                                              KEYWORDS    tuberculosis;  polypharmacy  burden;  elderly;
              Δ 基金项目 国家自然科学基金资助项目(No.81860591);贵州省
                                                              influencing factor
          科技计划项目(No.黔科合基础-ZK〔2022〕一般386);贵州医科大学高
          层次人才启动基金资助项目(No.校博合J字〔2020〕070号)
             *第一作者 硕士研究生。研究方向 :药事管理学。E-mail:                      结核病是由结核分枝杆菌感染引起的一种慢性呼
          huyuanxia@stu.gmc.edu.cn
                                                                        [1]
                                                              吸道传染病 ,是严重危害全球人类健康的重要公共卫
              # 通信作者 副教授,硕士生导师,博士。研究方向:药事管理学。
                                                                        [2]
          E-mail:luxiaolong@gmc.edu.cn                        生问题之一 。贵州省是我国结核病疫情高发地区,老
          · 1126 ·    China Pharmacy  2023 Vol. 34  No. 9                              中国药房  2023年第34卷第9期
   107   108   109   110   111   112   113   114   115   116   117